American Thyroid Association. Scientists & Physicians Dedicated to Better Understanding & Treatment of Thyroid Diseases.

ATA News Release 2008

Print page Email page
FALLS CHURCH, VA           
FOR IMMEDIATE RELEASE

Updated Guidelines for Managing Thyroid Cancer Presented at July 11-12 Scientific Meeting

April 4, 2008—Thyroid cancer experts will be presenting the latest recommendations in thyroid clinical care through the discussion of the American Thyroid Association’s (ATA) updated guidelines for patients with thyroid nodules and differentiated thyroid cancer at a regional workshop. The ATA’s “Frontiers in Thyroid Cancer: ATA Guidelines in Clinical Practice” will take place on July 11-12, 2008 at the Boston Park Plaza Hotel in Boston.

The new evidence-based guidelines, developed by an ATA task force of thyroid cancer experts, were published in Thyroid in 2006. The purpose of the updated guidelines was to provoke new ideas and address controversies regarding the diagnosis and initial management of thyroid cancer, given the rising incidence of the disease during the past three decades.

“For the first time, the ATA is bringing its updated Management Guidelines into the regional medical community to bring these state-of-the-art documents to life as their authors help clinicians from multiple disciplines apply these Guidelines to real patient care. Our goal is to help medical professionals and their patients by advancing the diagnosis and treatment of thyroid cancer," said Richard Kloos, M.D., program chair and secretary/chief operating officer of the ATA.

The workshop is designed to bring together endocrinologists, surgeons, nuclear medicine physicians and respective subspecialty fellows to address a variety of thyroid cancer topics, including:

  • Recent developments in the management of thyroid cancer and integration of new diagnostic and follow-up paradigms and the latest thyroid cancer therapies
  • Integrating changes in treatment that result from the evolving demography of thyroid cancer
  • The pathophysiology of thyroid cancer as it relates to new thyroid cancer drug therapies
  • New drugs in the management of differentiated thyroid carcinoma and medullary thyroid carcinoma

In 2008, thyroid cancer is expected to reach a record number of 37,340 newly diagnosed people in the United States, according to the U.S. Department of Health and Human Services and the American Cancer Society. Papillary thyroid cancer is the most common type, making up about 70% to 80% of all thyroid cancers and can occur at any age.

For more information, please contact the ATA at thyroid@thyroid.org.

For information about the Thyroid Cancer Workshop program, go to http://www.thyroid.org/ann_mtg/2008_Thyroid_Cancer_Workshop/index.html.

Over 25,000 free copies of the guidelines were downloaded form the ATA website between 2006-07, underscoring the educational need physicians have for understanding the diagnosis and treatment of thyroid cancer.

For a copy of the management guidelines, go to http://www.thyroid.org/professionals/publications/guidelines.html

 

Privacy Policy | Terms & Conditions | Contact Us
Site Design by Intertwine Systems, Inc.